Biocompatibility of graphene oxide intravenously administrated in mice—effects of dose, size and exposure protocols
Open Access
- 1 January 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 4 (1) , 83-91
Abstract
The toxicity of graphene oxide intravenously injected into mice was dramatically tuned by dose, size and exposure protocols of graphene oxide.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2011CB933402)
- National Natural Science Foundation of China (21071094)
This publication has 35 references indexed in Scilit:
- Effect of Size and Dose on The Biodistribution of Graphene Oxide in MiceNanomedicine, 2012
- Nanotoxicity assessment of quantum dots: from cellular to primate studiesChemical Society Reviews, 2012
- Nano-graphene in biomedicine: theranostic applicationsChemical Society Reviews, 2012
- Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical ApplicationsChemical Reviews, 2012
- Graphene Oxide: Preparation, Functionalization, and Electrochemical ApplicationsChemical Reviews, 2012
- Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxideBiomaterials, 2011
- Dendrimer Pharmacokinetics: The Effect of Size, Structure and Surface Characteristics on ADME PropertiesNanomedicine, 2011
- Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophagesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Functional Graphene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer DrugsSmall, 2010
- Electric Field Effect in Atomically Thin Carbon FilmsScience, 2004